This study tested the hypothesis that activated toll-like receptor-4 (TLR-4) is closely related to combined major adverse clinical outcomes (MACO) [defined as advanced Killip score (≥ 3), overt congestive heart failure (CHF) (New York Heart Association functional class ≥ 2) or 30-day death] in patients with ST-segment elevation (ST-se) acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI). We conducted a prospective cohort study in 43 consecutive patients with ST-se AMI of onset < 12 hours who were undergoing primary PCI. Blood samples for TLR-4 and serum level of tumor necrosis factor-α (TNF-α) were collected from 43 patients at 24 hours after AMI and from 20 normal outpatients. The experimental results revealed significantly higher baseline levels of TLR-4, TNF-α and white blood cell (WBC) count in the study patients than in normal control subjects (all P < 0.0001). Additionally, baseline levels of TLR-4, TNF-α , creatinine, peak level of CK-MB, and multiple vessel disease were significantly higher, whereas left ventricular performance was notably lower in patients (n = 18) with occurrence of MACO than in patients (n = 25) without occurrence of MACO (all P < 0.05). Furthermore, the level of lipopolysaccharide (LPS)-stimulated LTR-4 was significantly increased in MACO patients than in those without MACO (P < 0.0001). Moreover, LPS-stimulated TLR-4 was the most independent predictor of 30-day MACO (P < 0.01). In patients with ST-se AMI, activated TLR-4 is independently predictive of 30-day MACO. (Int Heart J 2008; 49: 1-11) 
system. 1, 5, [6] [7] [8] [9] [10] A substantial body of evidence has demonstrated that acute myocardial infarction (AMI) is associated with inflammation. 8, [11] [12] [13] Additionally, inflammation has an essential role in myocardial necrosis 7, 14) and microvascular reperfusion injury 9) in AMI patients. Therefore, inflammatory mechanisms should theoretically have an important role in occurrence of AMI and prognostic outcome following AMI. 8, 11, 13, 15) Innate immunity and inflammation are believed to play crucial roles in a wide range of pathologies, including heart disease and vasculopathies. 5, 16) Tolllike receptors (TLRs) are classic pattern recognition receptors, which are geneencoded proteins used by the innate immune system to recognize largely invariant pathogen-associated molecular patterns that are shared by the pathogen group, but at the same time not present in the host. 5, 17) Virtually all heart cells express TLRs, and TLR-2 to -4 and TLR-6 are readily detectable in cardiomyocytes. 5, 18) The TLR-4 receptor in peripheral monocytes is the major component of outer-membrane lipopolysaccharide (LPS) (gram-negative bacteria) which can induce a robust increase in the proinflammatory cytokines, tumor necrosis factorα (TNF-α) and interleukin-1β (IL-1β) within the myocardium by activating nuclear factor-κB. [18] [19] [20] Additionally, proinflammatory cytokines have been shown to participate in myocardial damage following AMI [11] [12] [13] Furthermore, experimental study has previously shown that a deficiency of TLR-4 in mice markedly inhibits inflammatory pathways, which in turn, reduces myocardial ischemia-reperfusion injury and thereby salvages the myocardium. 21) Therefore, it is rational to believe the hypothesis that TLR-4 expression in peripheral monocytes elicits an inflammatory reaction in response to myocardial ischemia. 22) However, the link between TLR4 expression and myocardial insult in AMI patients is seldom reported. 22) Therefore, the purpose of this study was to investigate whether TLR4 expression has prognostic value in ST-segment elevation (STse) AMI patients undergoing primary percutaneous coronary intervention (PCI).
METHODS

Patient population and inclusion criteria:
In our hospital, all patients with ST-se AMI are considered eligible for primary PCI. Between July and September, 2006, consecutive patients of any age who presented with AMI of < 12 hours duration undergoing primary PCI were prospectively enrolled and investigated.
To circumvent other potential influences on TLR-4 expression in peripheral monocytes and in circulating levels of TNF-α, patients with the following indications were excluded from the study: recent surgery or trauma during the preceding 2 months, renal insufficiency (creatinine > 1.5 mg/dL), malignancy, febrile disorders, acute or chronic inflammatory disease at study enrollment, autoim-mune diseases with or without immunosuppressive therapy, or prior myocardial infarction onset of < 3 months.
Twenty age-and gender-matched healthy volunteers were also assigned as a healthy control group at our health clinic center. Informed consent was obtained from each enrolled subject. The Institutional Review Committee on Human Research at our institution approved the study protocol. Procedure and protocol: A transradial artery approach using a 6-French arterial sheath is routinely applied for treatment of AMI at our hospital unless both hands Allen's test was positive. A 6-French Kimny guiding catheter (Boston Scientific, Scimed, Inc. Maple Grove, MN) was used for diagnosis and primary PCI.
Clopidogrel (300 mg loading dose before stenting and then 75 mg/day) was given to patients who underwent primary stenting. Aspirin (100 mg orally once a day) was given indefinitely to each patient. Other commonly prescribed drugs were angiotensin-converting enzyme inhibitors, beta-blockers, isonitrate, and diuretics. Blood sampling and isolated peripheral blood mononuclear cells: Blood samples (20 mL peripheral blood via venous puncture) were obtained once from both healthy volunteers enrolled after the healthy clinic examination and from patients from the coronary care unit (CCU) at 24 hours after AMI. All samples were stored in a vacutainer containing 3.8% buffered sodium heparin. Peripheral blood mononuclear cells (MNCs) were first isolated by density-gradient centrifugation (centrifuged at 400x g for 30 minutes) over Ficoll-Plaque 400 (Ficoll-Plaque TM plus, Amersham Biosciences, Sweden). The MNCs were then obtained from the interphase layer, washed twice with phosphate buffer solution (PBS) and centrifuged (2000 rpm for 5 minutes). The MNCs were suspended in 0.9 mL of RPMI-1640 medium (Sigma). Monocyte culture: The isolated MNCs were suspended in RPMI-1640 medium and then plated in 10 cm Petri dishes (Falcon), followed by incubation at 37°C with 5% CO 2 for 2 hours for monocyte attachment to the bottom of the Petri dish. The supernatant containing floating lymphocytes was discarded and then the dishes were rinsed twice with PBS. The monocytes were detached with a cell scraper. The monocytes were counted and the cell number adjusted to 1.0 × 10 6 cells/mL.
The TLR-4 expression in monocytes was obtained in the two culture mediums with and without LPS E. Coli (LPS, Sigma), based on a method described in a previous study. 20) Briefly, the monocytes (1 × 10 6 cells/mL) were categorized as the non-LPS-treated group [RPMI 1640 with 10% heart-inactivated FCS (Gibco BRL), penicillin, streptomycin and 10 µg/mL Brefeldin A (BFA, Sigma)] or LPStreated group (RPMI 1640 with 1 µg/mL LPS, 10% heart-inactivated FCS, penicillin, streptomycin and 10 µg/mL BFA). The monocytes were incubated in ster-ile polypropylene tubes (B & D Becton Dickinson, Mountain View, CA, USA) for 24 hours at 37°C in 5% CO 2 . Cell variability of > 95.0% was noted by Trypan Blue exclusion (Gibco BRL) of monocytes in each group. Flow cytometric measurement: By 24 hours after incubation, monocytes were incubated with a fluorescein isothiocyanate (FITC)-conjugated mouse against human CD14 antibody (Becton Dickinson). The TLR-4 was then stained with phycoerythrin (PE)-conjugated purified mouse anti-human TLR-4 antibody (eBioscine), followed by biotin [rat anti-mouse antibody (eBioscine)] and finally by PE-conjugated streptoavidin (SAVE) (eBioscine). Isotype IgG2a was used to detect any nonspecific association and to permit the definition of a threshold for activation-dependent binding. Quantitative two-color flow cytometric analysis was performed using a fluorescence-activated cell sorter (FACSCalibur TM system; Beckman Coulter). Each analysis included 10,000 cells per sample. The CD14-positive cells were selected by FITC emission and side scatter granularity. Histograms were then constructed utilizing CD-14-positive cells which allowed measurement of TLR-4 levels in monocytes using a mean fluorescence intensity (MFI) method. The assays for TLR-4 expression in each blood sample were performed in duplicate and the mean level was reported. Laboratory investigations: After centrifugation, the aliquots of the samples were stored at -80°C before assay for TNF-α . White blood cell (WBC) count and biochemical measurements were performed using standard laboratory methods.
Plasma TNF-α was measured by duplicate determination with a commercially available ELISA method (B & D Systems, Inc. Minneapolis, MN). The lower detection limit was 5 pg/mL. Intraindividual variability in TNF-α levels was assessed in study patients and control subjects. The mean intra-assay coefficients of variance were all less than 4.0%. Definitions and data collection: Acute myocardial infarction was defined as typical chest pain exceeding 30 minutes with ST-segment elevation > 1 mm in two or more consecutive precordial or inferior leads. Unsuccessful reperfusion was defined as failure to restore normal blood flow after PCI [≤ thrombolysis in myocardial infarction (TIMI)-2 flow] of the infarct-related artery. Reperfusion time was defined as the time from chest pain onset to the first balloon inflation. Multiple vessel disease was defined as ≥ 2 epicardial vessels with obstruction of ≥ 50%. Echocardiography was used to measure the left ventricular ejection fraction (LVEF) at 24 hours after AMI. Detailed in-hospital and follow-up data, including age, gender, coronary risk factors, serial MB fraction of creatine kinase (CK-MB) levels, WBC count, creatinine level, Killip score on admission, severity of congestive heart failure (CHF), angiographic findings, and number of diseased vessels were collected prospectively and entered into a computerized database. Endpoints and statistical analysis: The study endpoint was the 30-day composite (Table I) : Table I summarizes the baseline characteristics of the AMI patients and healthy control subjects. The two groups did not differ significantly in age, gender, body temperature or creatinine level. However, body mass index, WBC counts and TNF-α level were significantly higher in AMI patients than in healthy control subjects. Hypertension was the most common risk factor for coronary artery disease, followed by diabetes mellitus, a current smoking habit, and hypercholesterolemia in AMI patients. More than 23% of AMI patients exhibited an advanced Killip score upon presentation. Additionally, overt CHF and 30-day death occurred in 36% and 11% of AMI patients, respectively. Moreover, nearly 45% of combined 30-day MACO was observed in the present study.
RESULTS
Baseline characteristics of AMI Patients and healthy controls
Baseline characteristics, laboratory findings, and angiographic results in AMI
patients (Table II) : Patients with at least one MACO were categorized into group 1, and those with no MACO were assigned to group 2. The groups did not significantly differ in terms of gender, coronary artery disease risk factors, previous myocardial infarction, or WBC count. Additionally, left anterior descending artery occlusion, preinterventional TIMI flow ≤ 1, reperfusion time, stent implan- tation, and final TIMI-3 flow did not significantly differ between group 1 and group 2 patients. However, group 1 patients were significantly older than group 2 patients. Additionally, creatinine level, peak level of CK-MB, and plasma level of TNF-α were remarkably higher in group 1 than in group 2 patients. Moreover, left ventricular end diastolic dimension and left ventricular end systolic dimension were significantly higher in group 1 than in group 2 patients. Further, multiple vessel disease and LVEF were notably higher in group 1 than in group 2 patients. (Table III) : Table III shows TLR-4 expression in monocytes at baseline and after PLS stimulation in group 1 and 2 patients and in normal control subjects. Baseline TLR-4 expression was markedly higher in group 1 patients than in both group 2 patients and normal control subjects and significantly higher in group 2 patients than in normal control subjects. Additionally, TLR-4 expression following LPS stimulation (defined as activated TLR-4 expression) was substantially higher in group 1 than in group 2 and normal controls and notably higher in group 2 than in normal controls. Moreover, activated TLR-4 expression was also significantly higher than baseline TLR-4 expression among individual groups. Tables II and III demonstrated that baseline expression of TLR-4 , activated TLR-4 expression, TNF-α , LVEF, CK-MB, and multiple vessel disease were significantly associated with 30-day MCAO. Multiple stepwise logistic regression analysis demonstrated that activated TLR-4 expression was the most independent predictor of 30-day MACO. Additionally, age was also independently associated with 30-day MACO. 
Comparison of TLR-4 expression in monocytes before and after PLS stimulation
Determinants of 30-day MACO (Table IV and V): Univariate analysis of baseline variables in
DISCUSSION
This study investigated the impact of TLR-4 expression in patients with AMI undergoing primary PCI and yielded several noteworthy clinical implications. First, baseline TLR-4 expression, an index of innate immunity, was significantly higher in AMI patients than in normal control subjects. Second, the plasma level of TNF-α and activated TLR-4 expression, a reflex of chain reaction of innate immunity, were significantly higher in AMI patients than in normal control subjects. These findings, in addition to reinforcing previous experimental and observational studies, 5, [16] [17] [18] suggest that innate immunity elicits inflammatory responses in various clinical settings, including in AMI. Third, activated TLR-4 along with age was independently predictive of 30-day MACO, which is consistent with the findings of a recent clinical observational study. 22) Inflammation is a fundamental reaction instigated against virtually all injury types. Not surprisingly, different myocardial injuries can activate an inherent cardiac stress response, including proinflammatory cytokine expression. 5) Additionally, innate stress has been recently reported to play a central role in instigating and orchestrating immune responses within the heart and circulatory system. 5, 22) In the present study, we found that WBC count and baseline TLR-4, both of which are indices of inflammatory biomarkers, as well as TNF-α, an index of proinflammatory cytokine, were markedly higher in AMI patients than in normal control subjects. Thus, these findings further support those of recent investigations. 5, 22) The link between TLR-4 level and prognostic outcome in AMI patients undergoing primary PCI is seldom reported. A recent study by Satoh et al 22) demonstrated TLR-4 activated through a myocytic inflammatory reaction is associated with heart failure after AMI. The present study revealed that patients with high TLR-4 levels tended to exhibit an advanced Killip score upon presentation, overt CHF, and increased 30-day mortality. Of importance in the present study was that activated TLR-4 is the most independent predictor for 30-day MACO. Accordingly, these findings reinforce the findings of Satoh, et al 22) and further suggest that TLR-4 is a useful biomarker for early risk stratification following AMI.
Linde, et al 5) suggested that inflammation plays an important role in left ventricular remodeling following any type of cardiac insult. They further suggested that both innate and adaptive immunity as well as proinflammatory cytokines participate in the LV remodeling process. In the present study, we found that patients with high circulating levels of TNF-α and TLR-4 had remarkably lower LVEF and a higher incidence of overt CHF. Therefore, our finding further supports the suggestion of Linde, et al. 5) An association between advanced age and poor clinical outcome following AMI has been well recognized by previous studies. [23] [24] [25] In the current study, we also found that age is independently predictive of 30-day MACO. Therefore, our finding strengthens the previous findings [23] [24] [25] and further suggests that advanced age is a universal factor related to unfavorable outcome in patients with atherothrombotic cardiovascular disease.
When the peak level of TLR-4 is reached following AMI remains uncertain. Studies have previously demonstrated that many circulating levels of inflammatory cytokines and the acute phase of inflammatory C-reactive protein are always increased after AMI, starting several hours after onset of symptoms and reaching a peak level after 24 hours. 5, [11] [12] [13] 15, 26, 27) Thus, we speculate that a robust increase in TNF-α and IL-1β by activating nuclear factor-κB [18] [19] [20] could only occur several hours following AMI and the circulating levels of these proinflammatory cytokines could only reach a peak 24 hours after AMI. The collection of a blood sample 24 hours after onset of AMI has recently been revealed by Satoh, et al 22) to be an essential time interval for investigating the relationship between TLR-4 level and CHF. Accordingly, these are the reasons why we utilized 24-hour blood samples to investigate the association between TLR-4 level and 30-day clinical outcome in the current study.
This study has 2 limitations. First, the relatively small sample size may have distorted the statistical significance of some baseline variables as independent predictors of prognostic outcome when multiple stepwise logistic regression analysis was used. Second, the impact of TLR-4 on long-term clinical outcome was not part of the protocol designed; therefore, this relationship was not examined beyond short-term (30-day) clinical outcome.
In summary, expression of TLR-4 was notably enhanced in patients with STse AMI undergoing primary PCI. The analytical results of this investigation show that activated TLR-4 is a useful biomarker for early risk stratification following AMI.
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